Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)

BACKGROUND AND OBJECTIVE: Treatment with proton pump inhibitors (PPIs) has been associated with development of hepatic encephalopathy (HE). As development of HE is a major complication after implantation of a transjugular intrahepatic portosystemic shunt (TIPS), we hypothesized that PPI treatment ma...

詳細記述

保存先:
書誌詳細
出版年:United European Gastroenterol J
主要な著者: Sturm, Lukas, Bettinger, Dominik, Giesler, Max, Boettler, Tobias, Schmidt, Arthur, Buettner, Nico, Thimme, Robert, Schultheiss, Michael
フォーマット: Artigo
言語:Inglês
出版事項: SAGE Publications 2018
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206537/
https://ncbi.nlm.nih.gov/pubmed/30386611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640618795928
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料